PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Statistics

Total Valuation

PDSB has a market cap or net worth of $46.69 million. The enterprise value is $38.46 million.

Market Cap	46.69M
Enterprise Value	38.46M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

PDSB has 54.72 million shares outstanding. The number of shares has increased by 22.47% in one year.

Current Share Class	54.72M
Shares Outstanding	54.72M
Shares Change (YoY)	+22.47%
Shares Change (QoQ)	+2.11%
Owned by Insiders (%)	2.58%
Owned by Institutions (%)	10.16%
Float	53.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.31
P/TBV Ratio	4.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 1.90.

Current Ratio	2.09
Quick Ratio	1.97
Debt / Equity	1.90
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.06

Financial Efficiency

Return on equity (ROE) is -221.81% and return on invested capital (ROIC) is -54.38%.

Return on Equity (ROE)	-221.81%
Return on Assets (ROA)	-46.22%
Return on Invested Capital (ROIC)	-54.38%
Return on Capital Employed (ROCE)	-150.77%
Revenue Per Employee	n/a
Profits Per Employee	-$1.45M
Employee Count	24
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.17M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.59% in the last 52 weeks. The beta is 1.11, so PDSB's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	-52.59%
50-Day Moving Average	0.88
200-Day Moving Average	1.15
Relative Strength Index (RSI)	48.28
Average Volume (20 Days)	555,666

Short Selling Information

The latest short interest is 1.60 million, so 2.92% of the outstanding shares have been sold short.

Short Interest	1.60M
Short Previous Month	1.82M
Short % of Shares Out	2.92%
Short % of Float	2.99%
Short Ratio (days to cover)	2.46

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-32.23M
Pretax Income	-36.05M
Net Income	-34.88M
EBITDA	-32.17M
EBIT	-32.23M
Earnings Per Share (EPS)	-$0.81

Balance Sheet

The company has $26.20 million in cash and $17.97 million in debt, with a net cash position of $8.23 million or $0.15 per share.

Cash & Cash Equivalents	26.20M
Total Debt	17.97M
Net Cash	8.23M
Net Cash Per Share	$0.15
Equity (Book Value)	9.45M
Book Value Per Share	0.20
Working Capital	14.56M

Cash Flow

Operating Cash Flow	-32.28M
Capital Expenditures	n/a
Free Cash Flow	-32.28M
FCF Per Share	-$0.59

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PDSB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.47%
Shareholder Yield	-22.47%
Earnings Yield	-74.71%
FCF Yield	-69.14%

Analyst Forecast

The average price target for PDSB is $9.00, which is 954.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.00
Price Target Difference	954.73%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 18, 2019. It was a reverse split with a ratio of 1:20.

Last Split Date	Mar 18, 2019
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2